title: Do gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide contribute to the hyperinsulinaemia of pregnancy?
authors: Department of Clinical Biochemistry, Royal Surrey County, Guildford, United Kingdom.
authors: R
authors: R
authors: Gama
authors: K
authors: K
authors: Watkins
authors: L
authors: L
authors: Morgan
authors: J
authors: J
authors: Wright
authors: S
authors: S
authors: Hampton
authors: V
authors: V
authors: Marks
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000502:physiology; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood*; D005934:Glucagon / Q000097:blood*; D052216:Glucagon-Like Peptide 1; D005951:Glucose Tolerance Test; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood*; D007328:Insulin / Q000097:blood / Q000276:immunology; D010446:Peptide Fragments / Q000097:blood*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood*; D017697:Premenopause / Q000097:blood; D011498:Protein Precursors / Q000097:blood*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005934:Glucagon